STAT

National Academies outlines opioid guidelines, aiming to make approach to prescribing more consistent

As medical providers try to cut back on opioids prescriptions, they’ve wrestled with how to best do so. A new report offers some guidelines.
Source: ERIC BARADAT/AFP via Getty Images

As government agencies, medical groups, hospitals, and pharmacies have tried to cut back on opioid prescriptions, they’ve wrestled with how to best do so. Should they restrict the number of days a prescription lasts? Should there be a cap on the total strength of the dose? What kind of exceptions should be made?

A new report issued Thursday by the National Academies of

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks